BiotechTube
Home/Insulet/Wayde McMillan
WM

Wayde McMillan

Executive Vice President and Chief Financial Officer

Insulet

Therapeutic Areas

Type 1 DiabetesType 2 Diabetes (Insulin-requiring)

Insulet Pipeline

DrugIndicationPhase
Omnipod 5 Type 2 ExpansionType 2 Diabetes (Adults)Commercial
Omnipod 5 International RolloutType 1 & Type 2 DiabetesCommercial
Next-Gen Hardware/SoftwareDiabetes ManagementR&D
CGM Ecosystem IntegrationDiabetes ManagementDevelopment/Regulatory

Leadership Team at Insulet

JH
Jim Hollingshead, Ph.D.
President and Chief Executive Officer
BC
Bret Christensen
Chief Commercial Officer
DT
Dr. Trang Ly
Senior Vice President and Medical Director
DC
Dr. Charles Alessi
Chief Medical Officer (Interim)
MF
Mark Field
Chief Technology Officer
TS
Timothy Scannell
Chairman of the Board
View full Insulet profile